MENA PV Landscape – Key Updates & Inspection Trends
In this episode of Biomapas Insights, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, speaks with Mina Awad, a GxP Auditor, Inspector, and PV expert with over 17 years in the pharmaceutical industry. Based in the United Arab Emirates (UAE) and...
Navigating Pharmacovigilance Requirements in LATAM
In the first episode of our new video series, Biomapas Insights, Albert Bekfi, Head of Global PV Operations at Biomapas, is in conversation with Raul Flores Medina, Local Safety Officer for LATAM, about the evolving Pharmacovigilance landscape across the LATAM region....
Centralized Pharmacovigilance: Ensuring Compliance and Efficiency Across Global Markets
Pharmaceutical and biotech companies operate in a high-stakes regulatory environment where drug safety and compliance are non-negotiable. Expanding into new markets introduces additional challenges, requiring adherence to diverse regulatory frameworks across the...
Pharmacovigilance Auditing: Understanding the Process and Maximizing Its Benefits
What is the Pharmacovigilance Audit process? In healthcare, ensuring patient safety through the integrity examination and evaluation of pharmacovigilance systems, are priorities. This is where Pharmacovigilance (PV) Audits come into the spotlight. In an industry...
